The Use of Virus-like Particles as Immunogens to Treat Infectious Diseases.
Carregando...
Arquivos
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Bentham Science Publishers
Tipo
Artigo
Direito de acesso
Acesso restrito
Arquivos
Fontes externas
Fontes externas
Resumo
Virus-like particles (VLPs) represent a promising approach to developing vaccines for infectious diseases. These nanostructures mimic the organization and conformation of native viruses but lack viral genetic material, rendering them non-infectious. VLPs can induce potent immune responses, making them ideal immunogens. This review provides an overview of VLP technology, its application in combating infectious diseases, and its potential to shape future vaccine development. Specific emphasis is placed on current clinical applications, emerging infectious disease targets, and the challenges in optimizing VLP-based immunogens.
